IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MEREGALLI, MIRELLA ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.867
NA - Nord America 6.087
AS - Asia 5.234
SA - Sud America 615
AF - Africa 152
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 14
Totale 18.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.854
GB - Regno Unito 2.162
CN - Cina 1.900
SG - Singapore 1.646
DE - Germania 918
SE - Svezia 878
IT - Italia 858
RU - Federazione Russa 484
HK - Hong Kong 461
BR - Brasile 457
IN - India 345
NL - Olanda 320
UA - Ucraina 289
TR - Turchia 256
FR - Francia 227
IE - Irlanda 187
KR - Corea 187
FI - Finlandia 178
CA - Canada 170
EU - Europa 148
VN - Vietnam 101
PL - Polonia 90
CI - Costa d'Avorio 76
ID - Indonesia 69
CO - Colombia 68
GR - Grecia 60
JP - Giappone 59
BE - Belgio 48
MX - Messico 40
AR - Argentina 33
ES - Italia 31
BD - Bangladesh 29
DK - Danimarca 28
RO - Romania 25
CH - Svizzera 23
IQ - Iraq 20
UZ - Uzbekistan 20
IR - Iran 19
AU - Australia 18
MA - Marocco 16
IL - Israele 15
PK - Pakistan 15
TW - Taiwan 15
ZA - Sudafrica 15
VE - Venezuela 14
EC - Ecuador 12
AT - Austria 10
PY - Paraguay 10
SA - Arabia Saudita 10
LB - Libano 9
MY - Malesia 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
CL - Cile 7
EG - Egitto 7
KE - Kenya 7
PH - Filippine 7
SK - Slovacchia (Repubblica Slovacca) 7
JM - Giamaica 6
TH - Thailandia 6
TN - Tunisia 6
KZ - Kazakistan 5
LT - Lituania 5
SC - Seychelles 5
AL - Albania 4
AZ - Azerbaigian 4
BG - Bulgaria 4
NO - Norvegia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
DZ - Algeria 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
RS - Serbia 3
UY - Uruguay 3
BH - Bahrain 2
BO - Bolivia 2
HN - Honduras 2
HR - Croazia 2
JO - Giordania 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
NG - Nigeria 2
SI - Slovenia 2
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
BM - Bermuda 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CR - Costa Rica 1
Totale 19.109
Salva come PNG Salva come JPEG
Città #
Southend 1.974
Singapore 907
Ashburn 593
Chandler 564
Beijing 452
Hong Kong 445
Seattle 366
Milan 311
Princeton 271
Wilmington 250
Dallas 246
Jacksonville 204
Dublin 185
Council Bluffs 175
Mountain View 168
Fairfield 161
Ann Arbor 152
Frankfurt am Main 148
Nanjing 141
Redmond 141
Bengaluru 132
Santa Clara 132
Toronto 122
San Jose 121
Woodbridge 117
Munich 116
Los Angeles 112
Boardman 104
Phoenix 92
Sakarya 91
Des Moines 88
Dearborn 81
Buffalo 77
Abidjan 76
Warsaw 75
Medford 74
Moscow 73
Shanghai 71
Serra 63
Andover 62
Bogotá 59
Helsinki 58
Houston 58
Hanover 57
New York 56
São Paulo 56
Cambridge 55
Athens 54
Shenyang 52
Sunnyvale 51
Guangzhou 49
Jinan 46
Changsha 44
Somerville 42
Tianjin 42
Brussels 40
Columbus 39
Redwood City 37
Tokyo 37
Jakarta 36
Nanchang 35
Hefei 34
Cangzhou 32
Fuzhou 32
Hebei 32
Eitensheim 31
San Diego 30
Berlin 29
Rome 29
Chicago 28
Hangzhou 27
Bitonto 26
Ho Chi Minh City 26
London 26
The Dalles 25
Roxbury 24
Mumbai 23
Grafing 22
Hamburg 22
Odernheim 21
Quanzhou 21
Nuremberg 20
Zhengzhou 20
Hanoi 18
Ottawa 18
Wuhan 18
Seoul 15
Falls Church 14
Kunming 14
Auburn Hills 13
Falkenstein 13
Haikou 13
Jiaxing 13
Kiez 13
Turin 13
Boston 12
Nürnberg 12
Rio de Janeiro 12
Ankara 11
Orem 11
Totale 11.549
Salva come PNG Salva come JPEG
Nome #
Inositol 1,4,5-trisphosphate (IP3)-dependent Ca2+ signaling mediates delayed myogenesis in Duchenne muscular dystrophy fetal muscle 333
CD133+ cells isolated from various sources and their role in future clinical perspective 317
Modificazione genica di cellule staminali distrofiche allo scopo di trapianto autologo nella distrofia muscolare di Duchenne 297
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy 291
Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction 269
T and b lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse 251
Induction of neurotrophin expression via human adult mesenchymal stem cells : implication for cell therapy in neurodegenerative diseases 244
Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle 240
Autologous intramuscular transplantation of engineered satellite cells induces exosomemediated systemic expression of Fukutin-Related Protein and rescues disease phenotype in a murine model of Limb-Girdle Muscular Dystrophy Type 2I. 234
Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy 226
Characterization of muscle-specific expression of miRNAs in duchenne muscular dystrophy 225
High Mobility group protein 3 (Hmgb3) is regulated by microRNA-206 during muscle regeneration 223
Skin-derived stem cells transplanted into resorable guides provide functional nerve regeneration after sciatic nerve resection 218
Correlation of circulanting CD133+ progenitor subclasses with a Mild phenotype in Duchenne Muscular dystrophy patients 215
Morphological modifications of resected sciatic nerve after autologous transplantation of skin-derived stem cells into resorable guides. 213
Combining Stem Cell and Exon Skipping Approach to Treat Muscular Dystrophies 213
Advancements in stem cells treatment of skeletal muscle wasting 211
Stem cells and muscular dystrophies 210
Autologous transplantation of skin-derived stem cells and functional nerve regeneration after a peripheral nerve lesion 207
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 204
CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells 200
VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation 198
Isolation and characterization of cells coexpressing endothelial progenitors and parathyroid specific genes from human adult normal and tumoral parathyroids 191
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 190
Difference in myogenic properties of the blood-derived AC133+ stem cells subpopulation isolated from normal and dystrophic tissues 183
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 182
Impact of Muscular Dystrophy on the Regenerative Properties of interstitial Muscle Cells 182
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect 181
Human fetal CD133+ skeletal muscle cells expressing pericyte merkers generate muscle and endothelial cells and repair dystrophic muscle tissues. 179
Blood-derived CD133+ stem cells from normal and dystrophic tissues: a comparative study with clinical applications 178
Myogenic potential of human circulating AC133+ stem cells in murine dystrophic skeletal muscle 178
Cellule staminali e rigenerazione muscolare 178
Cell Therapy of Muscular Dystrophy with Engineered CD133+ Cells 178
Development of a new technique for muscle tissues-stem cells co-colture 178
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy 176
Cell Theraphy of Muscolar Dystrophy with Engineered CD133+Cell 175
Combining multiple therapeutic strategies for Friedreich’s ataxia (FRDA): antioxidant metallic nanoclusters as coadjuvants for gene and stem cell therapy 173
Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle 172
Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands 171
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy 170
In Vivo Tracking of Stem cell by Nanotechnologies : Future Prospect for Mouse to Human Translation 170
Differential Activativation of CD20-Related Signalling Pathway Results in Distinct Differentiation Behaviour of Normal and DMD Circulating CD133+ Stem Cells 170
In vitro and In Vivo mesenchymal stem cells neurothrophin production but limited neuronal differantiation 169
Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection 169
The involvement of microRNAs in neurodegenerative diseases 169
Role of skin derived stem cells in peripheral nerve regeneration 168
Combining Gene and Stem Cell therapy in the Treatment of Dysferlinophaties 168
The myomiR-206 partecipate to muscle-regeneration by sculpting the chromatin through the down.regulation of the non-histone chromatin-associated protein High Mobility group protein 3 (Hmgb3) 167
Exome sequencing identifies mutations in two genes encoding the LIM-proteins N-RAP and FHL1 in a BAG3 myofibrillar myopathy 167
Exome sequencing identifies variants in two genes encoding the lim-proteins n-rap and fhl1 in a bag3 myofibrillar myopathy 167
The role of stem cells in muscular dystrophy 166
Preclinical experience and perspectives of a clinical trial using cD133 stem cells 166
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy. 164
Combining gene and stem cell therapy in the treatment of disferlinopaties 163
Combining stem cells and exon skipping strategy to treat muscular dystrophy 162
Development of new technologies Including myogenic differentiation of human circulating CD133+cells 162
Muscle-specific microRNAs (mirnas) in Duchenne Muscular Distrophy (DMD). 157
Hmgb3 Is Regulated by MicroRNA-206 during Muscle Regeneration 157
Cell Based Therapy for Duchenne Muscular Dystrophy 156
Development of New technologies Inducing Myogenic Differentiation of Human Circulating CD133+ Cells 156
Muscular dystrophies therapies by engineered stem cells 156
Ex vivo expansion of human circulanting CD133+promising tool for cell-based therapeutic approaches in muscular dystrophy 155
Myogenic differentiation potential of CD133+ stem cells isolated from various sources 155
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 155
Differential Activation of CD20-related Signaling Pathways Results in distinct differentiation behaviour of normal and DMD circulating CD133+ Stem Cells 154
Absence of T and B lymphocytes enhances skeletal muscle regeneration and ameliorates dystrophic pathology in dysferlin deficient animal model 154
Predicted miRNAs in murine dystrophin gene 154
Ex vivo expansion of human circulating CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 152
In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled CD133+ stem cell tropism to dystrophic muscle tissues using micro-CT imaging 152
Stem Cell Therapies to Treat Muscular Dystrophy : Progress to Date 151
Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies. 150
Predicted miRNAs in murine dystrophin gene 150
CD133+ Cells for the Treatment of Degenerative Diseases : update and perspectives 150
Muscle-specific microRNAs (mirnas) in Duchenne Muscular Distrophy (DMD). 149
Ex vivo expansion of peripheral blood CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 147
Combining Stem Cells and Exon-Skipping and Approch to Treat Muscular Dystrophies 147
Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy 146
Autologous transplantation of engineered muscle-derived CD133+ stem cells 145
Duchenne muscular dystrophy caused by a frame-shift mutation in the acceptor splice site of intron 26 145
Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-Related Protein and rescues disease phenotype in a murine model of Limb-Girdle Muscular Dystrophy Type 2I 145
Mesenchymal Stem Cells as Muscle Reservoir 143
Abundance of Circulating Progenitors with Myo-Endothelial Potential Correlates with a Mild Phenotype in Patients Affected by Duchnne Muscular Dystrophy 142
Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs 142
MiRNAs dysregulation of Single Muscle Fibers in Duchenne Muscular Dystrophy 141
Proliferation and Clonal Analysis of Muscle Derived CD133+ Stem Cell Subpopulations Define a Depletion of Mesenchymal Population in DMD Patients 141
Adaptive immune response impairs the efficacy of autologous transplantation of engineered stem cells in dystrophic dogs 141
Proliferation and clonal characterization of human muscle derived CD133+ positive stem cells define an intrinsic heterogeneity 140
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 139
Full-length dysferlin expression driven by engineered human dystrophic blood-derived CD133+ stem cells 139
Rescue of human dystrophin after transplantation of exon-skipping-engineered DMD stem cells in a dystrophic animal model 136
Human Fetal CD133+ Muscle Cells Expressing Perycite Markers Repair Dystrophic Muscle Tissue. 135
Cell replacement therapy in neuromuscular and neurodegenerative diseases 134
Stem cell therapy of muscular dystrophies using exon skipping approach in GRMD dogs 132
Thermoresponsive material for muscle cell sheet engineering 130
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 129
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect 128
Proliferation and clonal Characterization of Human Muscle Derived CD133+ Stem Cell Define an Intrinsic Heterogeneity 127
Improvement of endurance of DMD animal model using natural polyphenols 127
Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice 126
MicroRNA-206 is Upregulated in an Animal Model of Duchenne Muscular Dystrophy 126
Totale 17.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.243
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021898 0 0 0 0 0 0 136 94 165 57 368 78
2021/20221.512 126 69 32 87 69 114 112 46 235 104 166 352
2022/20232.160 327 244 196 253 237 370 32 143 252 19 60 27
2023/20241.127 38 86 50 90 357 61 49 50 17 59 104 166
2024/20253.140 113 259 62 382 248 101 190 321 133 315 254 762
2025/20263.268 683 367 551 471 593 426 177 0 0 0 0 0
Totale 19.950